B8.048 Prework 1: Screening for and Diagnosis of Prostate Cancer Flashcards

1
Q

what is the prostate

A

a gland in the pelvis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

purpose of the prostate

A

reproduction
makes the seminal fluid (non-sperm) portion of the ejaculate to nourish sperm
stored in the seminal vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

composition of the prostate

A

glands: source of adenocarcinoma of the prostate
stroma: contains the suportive tissues such as the smooth muscle, vessels, and autonomic nerves, source of the non-adenocarcinoma prostate cancers (sarcomas)
seminal vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

risk factors for prostate cancer

A

increasing age
AA race/ethnicity
fam history of prostate, breast, ovarian, and pancreatic cancers
genetic syndromes/conditions: lynch, BRCA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

AUA screening guidelines

A

40-54: men at risk

55-69: shared decision making

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

american cancer society screening guidelines

A

50+: average risk with life expectancy > 10 years
45+: men at high risk
40+: men at highest risk, more than 1 first degree relative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

NCCN screening guidelines

A

45-75

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

USPSTF screening guidelines

A

55-69

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

should you screen men >70 for prostate cancer?

A

depends on their sitch

if they are going to live a while, yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PSA

A

protein produced by the prostate and secreted into seminal fluid to liquify semen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how does PSA get into the serum

A

loss of the basal cell layer (hallmark of prostate cancer histologically) results in leakage of PSA into blood stream > thus returning elevated levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2 components of prostate cancer screening

A

PSA and DRE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DRE

A

palpation of the prostate for nodularity

palpable lesion = 40% risk of incident prostate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

prostate zones

A

transition zone = 20%
central zone = 5%
peripheral zone = 70-80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

accuracy of a PSA screening

A

PSA > 4 used
-PPV 30%
-NPV 85%
unfortunately with PSA < 4, 15% of men will have high grade disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

why can people with PSA < 4 have high grade prostate cancer

A

younger men have smaller glands; less BPH driven PSA, so lower PSAs can be more concerning
prostate cancer cells can make less PSA by volume than normal prostate cells (not normally functioning cells)

17
Q

risks of prostate biopsy

A
discomfort
pain
bleeding (urine, stool, semen)
transient ED
infection (2-4% get post biopsy sepsis)
18
Q

contemporary schema for assembling of screening info

A

concern > shared decision making > PSA and DRE
if PSA elevated: biomarker or MRI > biopsy if abnormal
if abnormal DRE: prostate biopsy

19
Q

additional tests for prostate cancer screening

A

4K score
PHI
PCA3
MRI

20
Q

4K score

A

total PSA, free PSA, intact PSA, kallikrein-related peptide 2
clinical factors
AUC for clinically significant prostate cancer: 0.77-0.82 (better than PSA)

21
Q

PCA3

A

PCA3 ad PSA RNA in post DRE urine samples
approved in men with a negative prior biopsy
NPV 90%

22
Q

multi-parametric MRI with fusion biopsy

A
T2 weighted
dynamic contrast enhanced
diffusion weighted imaging
approved for men with a prior negative biopsy
-NPV: 90%
-PPV: 60%
23
Q

advantage of MRI over blood tests

A

approved (get coverage) and offers ability to target

24
Q

targeted biopsy

A

uses US and MRI fusion software
targets lesions identified on MRI for biopsy
tracks where biopsies were obtained

25
Q

lifetime risk of prostate cancer death across population

A

2.8%

26
Q

does PSA screening decrease mortality?

A

21% RR in cancer mortality
29% when adjusted for noncompliance
1.07 deaths per 1000 men

27
Q

NTT of PSA screening

A

781 men screened
12 cancers detected
to prevent 1 death at 13 years

28
Q

why not screen for prostate cancers?

A

large number screened to avert 1 death
false positive PSA values result in unnecessary biopsies
some men who receive treatment don’t need it